Showing results (721-730 of 3,256) with videos related to
Sort By:
Pageof 326
Scandinavian Journal of Rheumatology|September 21, 2012
Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritisN E Aikawa, L M A Campos, C Goldenstein-Schainberg, et al.Scandinavian Journal of Rheumatology|September 1, 2012
Apoptosis-associated speck-like protein containing a CARD (ASC) expression profiles in familial Mediterranean fever (FMF) patients with different MEFV mutation patternsS Nalbantoglu, B Tanyolac, A BerdeliScandinavian Journal of Rheumatology|July 26, 2012
The prevalence and clinical characteristics of systemic lupus erythematosus with infectious brain lesions in ChinaY Xu, D Xu, T Zhang, et al.Scandinavian Journal of Rheumatology|July 19, 2012
Functional disability and health-related quality of life in South Africans with early rheumatoid arthritisB Hodkinson, E Musenge, M Ally, et al.Scandinavian Journal of Rheumatology|July 19, 2012
Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trialM Hakala, H Kröger, H Valleala, et al.Scandinavian Journal of Rheumatology|July 31, 2012
Achieving treat to target in gout: a clinical practice improvement projectA Y N Lim, L Shen, C H Tan, et al.Scandinavian Journal of Rheumatology|September 29, 1998
Effects of static and dynamic shoulder rotator exercises in women with rheumatoid arthritis: a randomised comparison of impairment, disability, handicap, and healthC Boström, K Harms-Ringdahl, H Karreskog, et al.Scandinavian Journal of Rheumatology|September 29, 1998
Soluble cell adhesion molecules--P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritisD J Veale, C Maple, G Kirk, et al.Scandinavian Journal of Rheumatology|September 29, 1998
Suboptimal clinical response to anti-tumor necrosis factor alpha (TNFalpha) antibody therapy in a patient with severe rheumatoid arthritis and lymphadenopathyY Saeki, S Ohshima, T Mima, et al.Pageof 326